首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Medicinal Research Reviews

Medicinal Research Reviews杂志,由John Wiley and Sons Inc.出版,于1981年创刊,Bimonthly,出版语言English,ISSN:0198-6325,E-ISSN:1098-1128。

投稿咨询
Medicinal Research Reviews
Medicinal Research Reviews
Medicinal Research Reviews
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
13.6
CiteScore
29.1
期刊收录
SCI、SCIE

Medicinal Research Reviews(中文译名:《医学研究评论》),ISSN:0198-6325,EISSN:1098-1128,是John Wiley and Sons Inc.出版的国际性学术期刊,创刊于1981年,以Bimonthly形式稳定发行,2026年总发文量约57篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、药物化学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达13.6,2025年期刊CiteScore为29.1,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Medicinal Research Reviews长期聚焦医学、药物化学及相关产业的技术应用前沿,平均审稿周期约稿?周期不定,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药物化学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、India、Italy、Spain、Australia、Canada等为核心发文国家与地区;CHINESE ACADEMY OF SCIENCESUNIVERSITY SYSTEM OF GEORGIA、RUSSIAN ACADEMY OF SCIENCES、UNIVERSITY OF TEXAS SYSTEM、LANZHOU UNIVERSITY、UNIVERSITY OF NORTH CAROLINA、UNIVERSITY OF QUEENSLAND等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CHEMISTRY, MEDICINAL 药物化学 PHARMACOLOGY & PHARMACY 药学
1区 1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CHEMISTRY, MEDICINAL 药物化学 PHARMACOLOGY & PHARMACY 药学
1区 1区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
CHEMISTRY, MEDICINAL 药物化学 PHARMACOLOGY & PHARMACY 药学
1区 1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q1 1 / 72

99.3

学科:PHARMACOLOGY & PHARMACY SCIE Q1 9 / 356

97.6

学科:CHEMISTRY, MEDICINAL SCIE Q1 3 / 72

96.53

学科:PHARMACOLOGY & PHARMACY SCIE Q1 24 / 356

93.4

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q1 1 / 72

99.3

学科:PHARMACOLOGY & PHARMACY SCIE Q1 11 / 352

97

学科:CHEMISTRY, MEDICINAL SCIE Q1 3 / 72

96.53

学科:PHARMACOLOGY & PHARMACY SCIE Q1 22 / 353

93.91


中国学者近期发文

1
Aldo-Keto Reductase Family 1 Member B10 as a Therapeutic Frontier: Advances in Inhibitor Design and Multimodal Approache

Author:Shao, Jikuan; Wang, Xiaolong; Guo, Can; Xing, Shuaishuai; Sun, Haopeng

Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70050

2
Tirzepatide in Metabolic Diseases: Clinical Efficacy and Safety Beyond Diabetes and Obesit

Author:Dong, Shixuan; Xu, Ying; Gan, Ran; Zhang, Ailin; He, Jinhan; Tang, Qin

Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70049

3
Unravelling Structure-Based Molecular Activation and Antagonism of Protease-Activated Receptors for Drug Desig

Author:Xu, Zhikang; Li, Rui; Zhang, Jian

Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70048

4
Comparative Pharmacology of Caspase-1 Inhibitors: Ac-YVAD-CMK, Z-YVAD-FMK, and Ac-YVAD-CHO in Multisystem Disease

Author:Zheng, Yujia; Dou, Baolei; Ren, Yifan; Zhang, Xiangyi; Zhang, Ruifeng; Zhang, Guangming; Yang, Lin; Zeng, Miao; Gan, Jiali; Jiang, Xijuan; Xu, Pengjuan

Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70045

5
Mucin O-Glycosylation and Mucolytic Therapies in Pseudomyxoma Peritonei: Literature Revie

Author:Zhao, Qi-Di; Morris, David L.; Sun, Zheng-Long; Li, Yan

Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70051

6
Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Function

Author:Bai, Linyue; Shen, Liang; Zhang, Qianqian; Hu, Zhuang; Tang, Yanjun; Fu, Mengjie; Fan, Yange; Wang, Huifeng; Liu, Hong-Min; Dai, Xing-Jie; Feng, Siqi

Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70034

7
Recent Advances of Non-Nucleoside Polymerase Inhibitors With Broad-Spectrum Antiviral Activitie

Author:Tao, Sining; Zhou, Zhenzhen; Li, Xin; Wang, Xian-wei; Liu, Xinyong; Kang, Dongwei

Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70041

8
A Comprehensive Review of Marketed KRAS Inhibitors and Degraders: Challenges and Opportunitie

Author:Xu, Yi-Xin; Bai, Yi-Ru; Li, Ruifang; Peng, Yi-Ming; Liu, Ting-Ting; Yang, Xin; Chen, Ke-Tong; Jin, Zhi-Peng; Liu, Hong-Min; Yuan, Shuo

Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70035

9
Unlocking Multiscale Allosteric Mechanisms: Advanced Computational Strategies for Drug Discover

Author:Zhu, Ruidi; Wu, Chengwei; Li, Mingyu; Liu, Xinyi; Zhang, Jian

Journal: MEDICINAL RESEARCH REVIEWS. 2026; Vol. , Issue , pp. -. DOI: 10.1002/med.70036

10
3D Bioprinting for Engineering Organoids and Organ-on-a-Chip: Developments and Application

Author:Ren, Yuqing; Yuan, Congying; Liang, Qimeng; Ba, Yuhao; Xu, Hui; Weng, Siyuan; Zhang, Yuyuan; Zuo, Anning; Liu, Shutong; Luo, Peng; Chen, Quan; Zhou, Zhaokai; Zhang, Chuhan; Chen, Yukang; Liu, Zaoqu; Han, Xinwei

Journal: MEDICINAL RESEARCH REVIEWS. 2025; Vol. , Issue , pp. -. DOI: 10.1002/med.22121


在线咨询

Medicinal Research Reviews

国际简称:MED RES REV参考译名:医学研究评论

年发文量:57 CiteScore:29.1 是否预警:否 Gold OA文章占比:29.15% 研究类文章占比:0.00%

杂志社联系方式:JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030

Medicinal Research Reviews